**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 129541-43-1 |5-Bromo-4-chloro-3-indoxyl butyrate | | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Air sensitive.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the
skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if
swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin
and eyes.
Storage:
Store in a tightly closed container. Deep freeze (below -20C).
Store under an inert atmosphere.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 129541-43-1:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white to off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 91 - 93 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: C12H11BrClNO2
Molecular Weight: 316.59
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, light, exposure to air.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide,
hydrogen bromide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 129541-43-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-Bromo-4-chloro-3-indoxyl butyrate -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 129541-43-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 129541-43-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 129541-43-1 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 4/03/2003 Revision #0 Date: Original.
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Cobalt (II) Nitrate Hexahydrate
| 10026-22-9 |
|
Stearyl stearate
| 2778-96-3 |
|
Glycerine trioleate
| 122-32-7 |
|
5-Bromo-4-chloro-3-indoxyl-??-D-xylopyranoside
| 207606-55-1 |
|
Cobalt oxide
| 1307-96-6 |
|
2-(6-Bromonaphthyl)-??-D-xylopyranoside hydrate
| 0-01-1 |
|
5-(4-Fluorophenyl)valeric acid
| 24484-22-8 |
|
6-Methoxyindole
| 3189-13-7 |
|
Alpha,Alpha-Trehalose, 99+%
| 99-20-7 |
|
3-Amino-9-fluorenone
| 6276-05-7 |
|
Methyl linolenate
| 301-00-8 |
|
5-Bromo-4-chloro-3-indoxyl butyrate
| 129541-43-1 |
|
6-Amino-1-methyluracil, 97%
| 2434-53-9 |
|
2,3-Dimethylbenzofuran, 99%
| 3782-00-1 |
|
6-Amino-1-methyl-5-nitrosouracil, 97%
| 6972-78-7 |
|
2-Aminoethyl dihydrogen phosphate, 95%
| 1071-23-4 |
|
4-Iodophenoxymethyl polystyrene resin, 1% cross-linked with DVB,
| 00-01-1 |
|
Iodo polystyrene resin, 50-100 mesh
| 00-01-1 |
|
(+/-)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl
| 98327-87-8 |
|
4,6-Dimethoxysalicylaldehyde
| 708-76-9 |
|
Acid orange 63
| 15792-50-4 |
|
N-BOC-L-tert-Leucine
| 62965-35-9 |
|
5-Nitro-3-pyrazolecarboxylic acid
| 198348-89-9 |
|
3,4,5-Trifluorophenylboronic acid
| 143418-49-9 |
|
2-Fluoro-4-hydroxybenzonitrile
| 82380-18-5 |
|
Guanosine Hydrate, 99%
| 118-00-3 |
|
(1S,2R)-2-Amino-1,2-diphenylethanol
| 23364-44-5 |
|
2-Amino-4-(trifluoromethyl)benzenethiol hydrochloride
| 4274-38-8 |
|
o-Toluic hydrazide
| 7658-80-2 |
|
Sodium glycocholate hydrate
| 207614-05-9 |
|
1,11-Undecanedicarboxylic acid, 94%
| 505-52-2 |
|
1-Decanesulfonic acid, sodium salt, 96%
| 13419-61-9 |
|
4-Chloro-5-(2-thienyl)thieno[2,3-d]pyrimidine, 97%
| 189681-04-7 |
|
2-Methyl-4-(2-thienyl)-1,3-thiazole, 90+%
| 21036-67-9 |
|
3-(Oxiran-2-ylmethoxy)benzaldehyde, 97%
| 22590-64-3 |
|
2-(1,4-Diazepan-1-yl)ethan-1-ol, 97%
| 53427-65-9 |
|
1-[3-Chloro-5-(trifluoromethyl)-2-pyridyl]-1,4-diazepane, 97%
| 231953-40-5 |
|
Cobalt (II) acetate tetrahydrate
| 6147-53-1 |
|
tert-Butyl 1,4-diazepane-1-carboxylate, 97%
| 112275-50-0 |
|
Tris-(4-Bromophenyl)-Aminium Hexachloro-Antimonate, 98%
| 24964-91-8 |
|
tert-Butyl n-(2-aminoethyl)carbamate, 97%
| 57260-73-8 |
|
5-(1,4-Diazepan-1-yl)-3-phenyl-1,2,4-thiadiazole, 97%
| 306934-71-4 |
|
tert-Butyl n-{2-[2-amino-4-(trifluoromethyl)anilino]ethyl}carbamate,
| 215655-42-8 |
|
tert-Butyl 4-(2-hydroxyethyl)piperazine-1-carboxylate, 97%
| 77279-24-4 |
|
1-[4-(Trifluoromethyl)pyrimidin-2-yl]-1,4-diazepane, 97%
| 238403-48-0 |
|
1-(2-Chloro-6-fluorobenzyl)-1,4-diazepane, 97%
| 244022-69-3 |
|
1-(4-Fluorobenzyl)-1,4-diazepane, 97%
| 76141-89-4 |
|
1-(2-Chloro-6-fluorobenzyl)piperazine, 97%
| 215655-20-2 |
|
1-(5-Nitro-2-pyridyl)-1,4-diazepane, 97%
| 287114-27-6 |
|
N-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]propane-1,3-diamine, 95+%
| 465514-63-0 |
|
|